A dose-escalation and pharmacokinetic study of subcutaneously administered recombinant human interleukin 12 and its biological effects in Japanese patients with advanced malignancies.
Year: 2000
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: R Ohno, Y Yamaguchi, T Toge, T Kinouchi, T Kotake, M Shibata, Y Kiyohara, S Ikeda, I Fukui, A Gohchi, Y Sugiyama, S Saji, S Hazama, M Oka, K Ohnishi, Y Ohhashi, S Tsukagoshi, T Taguchi
Institutions: Hamamatsu University, Hamamatsu University School of Medicine
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2119723878